Amgen Inc. Executive Compensation
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Named Executive Officers — FY2024
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Amgen Inc. discloses FY2024 compensation for 5 named executive officers, totaling $63.8M. Robert Bradway, the Chairman & CEO, accounts for 38% of that combined total.
Cash compensation (salary plus bonus) made up 12% of Amgen Inc.'s FY2024 tracked executive pay, with stock awards accounting for 69%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Amgen Inc.'s combined tracked executive pay of $63.8M ranks in the 99th percentile (industry median: $12.5M). Its highest-paid executive, Robert Bradway, ranks in the 97th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Amgen Inc. come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.